Doximity Inc(DOCS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 29.3 | EPS (ttm) | 0.84 | Insider Own | 31.14% | Shs Outstand | 128.9M | Perf Week | -6.12% |
| Market Cap | 4.40B | Forward P/E | 15.9 | EPS next Y | 15.51% | Insider Trans | -0.06% | Shs Float | 122.7M | Perf Month | -5.36% |
| Enterprise Value | 3.73B | PEG | 2.52 | EPS next Q | 0.34 | Inst Own | 72.78% | Short Float | 15.02% | Perf Quarter | 22.08% |
| Income | 0.17B | P/S | 6.72 | EPS this Y | -11.46% | Inst Trans | 1.05% | Short Ratio | 3.98 | Perf Half Y | 0.28% |
| Sales | 0.66B | P/B | 4.85 | EPS next 5Y | 6.3% | ROA | 14.6% | Short Interest | 18.43M | Perf YTD | -44.2% |
| Book/sh | 5.09 | P/C | 6.4 | EPS past 3/5Y | 23.05% 52.71% | ROE | 17.21% | 52W High | -67.7% ($76.51) | Perf Year | -64.19% |
| Cash/sh | 3.86 | P/FCF | 14.83 | Sales past 3/5Y | 15.45% 25.53% | ROIC | 18.09% | 52W Low | 44.08% ($17.15) | Perf 3Y | 8.9% |
| Dividend Est. | - | EV/EBITDA | 16.89 | EPS Y/Y TTM | -28.59% | Gross Margin | 87.41% | Volatility(W/M) | 3.37% 4.22% | Perf 5Y | -75.78% |
| Dividend TTM | - | EV/Sales | 5.68 | Sales Y/Y TTM | 11.18% | Oper. Margin | 30.57% | ATR (14) | 1.32 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 6.04 | EPS Q/Q | -52.02% | Profit Margin | 25.48% | RSI (14) | 49.18 | Recom | 2.48 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.04 | Sales Q/Q | 7.34% | SMA20 | -3.31% ($25.56) | Beta | 1.24 | Target Price | $30.68 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2026/8/6 | SMA50 | 5.05% ($23.52) | Rel Volume | 0.63 | Prev Close | $24.19 |
| Employees | 880 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | -4.26% 3.19% | SMA200 | -13.36% ($28.52) | Avg Volume(3M) | 4.63M | Price | $24.71 |
| IPO | 2021/6/24 | Option/Short | Yes/Yes | Trades | 20396 | Volume | 2,936,742 | Change | 2.15% |
Company
DOCS is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A healthcare technology company that operates a digital platform for medical professionals. It offers a professional network for physicians and other medical professionals, digital marketing services for pharmaceutical companies, and telehealth tools, with strengths in its extensive medical professional network and high profitability. The company operates in the medical professional platform sector.
Over the past 1 year, on the lower side
68% below its 1-year high.
DOCS makes money exceptionally well
30.57% of revenue is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -11.5% this year.
Tap to view numbers
The price looks about right
Trading at 29.3 times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +8.9% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 72.8%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
HEAL 0.03%
LGHT 0.02%
SMLL 0.02%
EKG 0.01%
MCOW 0.01%It ranks #4 in the industry
Based on market cap of $4B.
DOCS $4B PER 29.3
VEEV $42B PER 42.9
BTSG $11B PER 43.2
TEM $11B PER -
FAQ
What kind of company is DOCS?
DOCS belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of DOCS?
The market cap of DOCS is approximately $4.4B, ranking 1,487 within its sector.
What is the P/E ratio of DOCS?
DOCS has a P/E ratio of approximately 29.3x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for DOCS?
DOCS has recorded a 52-week high of $76.51 and a low of $17.15.
